Novel mRNA vaccines encoding Monkeypox virus proteins show promise in preclinical studies

By | November 23, 2022
In a recent study posted to the bioRxiv* preprint server, researchers in China demonstrated the efficacy of three messenger ribonucleic acid (mRNA) technology-based Monkeypox virus (MPXV) vaccines in combating a lethal Vaccinia virus (VACV) challenge in mice models.